National Research Corporation (NRC)
USD 10.71
(-4.16%)
USD 10.71
(-4.16%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 52.52 Million USD | -2.91% |
| 2022 | 47.97 Million USD | 5.83% |
| 2021 | 45.33 Million USD | 8.08% |
| 2020 | 41.94 Million USD | 8.92% |
| 2019 | 38.51 Million USD | 4.56% |
| 2018 | 36.83 Million USD | 7.48% |
| 2017 | 34.27 Million USD | 5.1% |
| 2016 | 32.61 Million USD | 4.23% |
| 2015 | 31.28 Million USD | 8.55% |
| 2014 | 28.82 Million USD | -0.41% |
| 2013 | 28.94 Million USD | 2.48% |
| 2012 | 28.24 Million USD | -0.44% |
| 2011 | 28.36 Million USD | 13.89% |
| 2010 | 24.9 Million USD | 28.24% |
| 2009 | 19.42 Million USD | 26.0% |
| 2008 | 15.41 Million USD | -2.18% |
| 2007 | 15.75 Million USD | 9.28% |
| 2006 | 14.41 Million USD | 38.91% |
| 2005 | 10.37 Million USD | 10.27% |
| 2004 | 9.41 Million USD | 18.72% |
| 2003 | 7.92 Million USD | 23.63% |
| 2002 | 6.41 Million USD | -7.09% |
| 2001 | 6.9 Million USD | 17.55% |
| 2000 | 5.87 Million USD | 17.44% |
| 1999 | 5 Million USD | -3.85% |
| 1998 | 5.2 Million USD | 23.81% |
| 1997 | 4.2 Million USD | 27.27% |
| 1996 | 3.3 Million USD | 32.9% |
| 1995 | 2.48 Million USD | 16.57% |
| 1994 | 2.13 Million USD | 75.02% |
| 1993 | 1.21 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 11.21 Million USD | 1.32% |
| 2024 Q2 | 11.22 Million USD | 0.04% |
| 2024 Q3 | 10.98 Million USD | 11.7% |
| 2023 Q3 | 13.35 Million USD | -0.96% |
| 2023 Q4 | 11.07 Million USD | -17.12% |
| 2023 FY | 46.58 Million USD | -2.91% |
| 2023 Q1 | 13.17 Million USD | 10.58% |
| 2023 Q2 | 13.48 Million USD | 2.35% |
| 2022 Q4 | 11.91 Million USD | -1.18% |
| 2022 Q2 | 12.03 Million USD | 0.61% |
| 2022 FY | 47.97 Million USD | 5.83% |
| 2022 Q1 | 11.96 Million USD | 6.28% |
| 2022 Q3 | 12.05 Million USD | 0.17% |
| 2021 Q1 | 11.5 Million USD | -2.25% |
| 2021 FY | 45.33 Million USD | 8.08% |
| 2021 Q2 | 11.65 Million USD | 1.27% |
| 2021 Q4 | 11.25 Million USD | 3.08% |
| 2021 Q3 | 10.92 Million USD | -6.25% |
| 2020 Q1 | 10.12 Million USD | 6.58% |
| 2020 Q2 | 10.25 Million USD | 1.35% |
| 2020 Q3 | 9.8 Million USD | -4.46% |
| 2020 Q4 | 11.76 Million USD | 20.09% |
| 2020 FY | 41.94 Million USD | 8.92% |
| 2019 Q1 | 9.12 Million USD | -2.46% |
| 2019 Q2 | 9.75 Million USD | 6.98% |
| 2019 Q3 | 10.13 Million USD | 3.86% |
| 2019 Q4 | 9.49 Million USD | -6.32% |
| 2019 FY | 38.51 Million USD | 4.56% |
| 2018 Q4 | 9.35 Million USD | 3.14% |
| 2018 Q3 | 9.06 Million USD | -2.14% |
| 2018 FY | 36.83 Million USD | 7.48% |
| 2018 Q2 | 9.26 Million USD | 1.26% |
| 2018 Q1 | 9.15 Million USD | 3.11% |
| 2017 Q1 | 7.79 Million USD | 1.22% |
| 2017 FY | 34.27 Million USD | 5.1% |
| 2017 Q4 | 8.87 Million USD | -7.2% |
| 2017 Q3 | 9.56 Million USD | 18.87% |
| 2017 Q2 | 8.04 Million USD | 3.23% |
| 2016 Q3 | 8.22 Million USD | -1.64% |
| 2016 FY | 32.61 Million USD | 4.23% |
| 2016 Q2 | 8.36 Million USD | 0.44% |
| 2016 Q1 | 8.32 Million USD | 14.13% |
| 2016 Q4 | 7.69 Million USD | -6.41% |
| 2015 Q4 | 7.29 Million USD | -5.15% |
| 2015 Q2 | 7.66 Million USD | -11.36% |
| 2015 Q1 | 8.64 Million USD | 9.99% |
| 2015 FY | 31.28 Million USD | 8.55% |
| 2015 Q3 | 7.69 Million USD | 0.39% |
| 2014 Q4 | 7.85 Million USD | 16.33% |
| 2014 FY | 28.82 Million USD | -0.41% |
| 2014 Q3 | 6.75 Million USD | -2.26% |
| 2014 Q2 | 6.91 Million USD | -5.36% |
| 2014 Q1 | 7.3 Million USD | 0.73% |
| 2013 Q2 | 7.32 Million USD | -1.63% |
| 2013 Q1 | 7.44 Million USD | 4.92% |
| 2013 FY | 28.94 Million USD | 2.48% |
| 2013 Q4 | 7.24 Million USD | 4.65% |
| 2013 Q3 | 6.92 Million USD | -5.41% |
| 2012 Q2 | 6.78 Million USD | -8.26% |
| 2012 Q3 | 6.97 Million USD | 2.76% |
| 2012 FY | 28.24 Million USD | -0.44% |
| 2012 Q4 | 7.09 Million USD | 1.78% |
| 2012 Q1 | 7.39 Million USD | 6.79% |
| 2011 Q1 | 7.33 Million USD | 1.02% |
| 2011 Q2 | 7.22 Million USD | -1.47% |
| 2011 Q3 | 6.88 Million USD | -4.72% |
| 2011 Q4 | 6.92 Million USD | 0.58% |
| 2011 FY | 28.36 Million USD | 13.89% |
| 2010 FY | 24.9 Million USD | 28.24% |
| 2010 Q1 | 5.56 Million USD | 11.99% |
| 2010 Q2 | 5.6 Million USD | 0.66% |
| 2010 Q3 | 6.47 Million USD | 15.54% |
| 2010 Q4 | 7.25 Million USD | 12.11% |
| 2009 Q2 | 4.58 Million USD | -9.86% |
| 2009 FY | 19.42 Million USD | 26.0% |
| 2009 Q4 | 4.97 Million USD | 4.15% |
| 2009 Q3 | 4.77 Million USD | 4.03% |
| 2009 Q1 | 5.08 Million USD | 47.51% |
| 2008 Q1 | 4.22 Million USD | 7.14% |
| 2008 FY | 15.41 Million USD | -2.18% |
| 2008 Q2 | 4.02 Million USD | -4.77% |
| 2008 Q4 | 3.45 Million USD | -7.08% |
| 2008 Q3 | 3.71 Million USD | -7.72% |
| 2007 Q1 | 4.02 Million USD | 4.9% |
| 2007 FY | 15.75 Million USD | 9.28% |
| 2007 Q4 | 3.94 Million USD | 0.82% |
| 2007 Q3 | 3.91 Million USD | 0.98% |
| 2007 Q2 | 3.87 Million USD | -3.81% |
| 2006 Q2 | 3.54 Million USD | 1.9% |
| 2006 Q1 | 3.47 Million USD | 42.48% |
| 2006 Q3 | 3.56 Million USD | 0.52% |
| 2006 Q4 | 3.83 Million USD | 7.83% |
| 2006 FY | 14.41 Million USD | 38.91% |
| 2005 Q1 | 2.6 Million USD | 11.39% |
| 2005 Q2 | 2.54 Million USD | -2.54% |
| 2005 Q4 | 2.43 Million USD | -12.46% |
| 2005 FY | 10.37 Million USD | 10.27% |
| 2005 Q3 | 2.78 Million USD | 9.61% |
| 2004 Q4 | 2.34 Million USD | -0.84% |
| 2004 Q3 | 2.36 Million USD | 0.99% |
| 2004 Q2 | 2.33 Million USD | -1.22% |
| 2004 Q1 | 2.36 Million USD | 13.67% |
| 2004 FY | 9.41 Million USD | 18.72% |
| 2003 Q1 | 1.72 Million USD | 6.3% |
| 2003 FY | 7.92 Million USD | 23.63% |
| 2003 Q4 | 2.08 Million USD | -0.78% |
| 2003 Q3 | 2.09 Million USD | 4.19% |
| 2003 Q2 | 2.01 Million USD | 16.49% |
| 2002 Q4 | 1.62 Million USD | 1.62% |
| 2002 Q3 | 1.6 Million USD | 6.33% |
| 2002 Q1 | 1.67 Million USD | -16.43% |
| 2002 FY | 6.41 Million USD | -7.09% |
| 2002 Q2 | 1.5 Million USD | -10.26% |
| 2001 Q3 | 1.89 Million USD | 18.81% |
| 2001 FY | 6.9 Million USD | 17.55% |
| 2001 Q4 | 2 Million USD | 6.07% |
| 2001 Q1 | 1.35 Million USD | -24.59% |
| 2001 Q2 | 1.59 Million USD | 17.48% |
| 2000 Q3 | 1.3 Million USD | -9.58% |
| 2000 FY | 5.87 Million USD | 17.44% |
| 2000 Q4 | 1.79 Million USD | 37.82% |
| 2000 Q2 | 1.44 Million USD | 8.95% |
| 2000 Q1 | 1.32 Million USD | -5.38% |
| 1999 Q2 | 1.2 Million USD | 9.09% |
| 1999 Q1 | 1.1 Million USD | -15.38% |
| 1999 Q4 | 1.4 Million USD | 7.69% |
| 1999 Q3 | 1.3 Million USD | 8.33% |
| 1999 FY | 5 Million USD | -3.85% |
| 1998 Q4 | 1.3 Million USD | 0.0% |
| 1998 Q3 | 1.3 Million USD | 0.0% |
| 1998 Q2 | 1.3 Million USD | 0.0% |
| 1998 Q1 | 1.3 Million USD | 111.4% |
| 1998 FY | 5.2 Million USD | 23.81% |
| 1997 FY | 4.2 Million USD | 27.27% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q4 | -11.4 Million USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 FY | 3.3 Million USD | 32.9% |
| 1995 FY | 2.48 Million USD | 16.57% |
| 1994 FY | 2.13 Million USD | 75.02% |
| 1993 FY | 1.21 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ontrak, Inc. | 29.47 Million USD | -78.185% |
| iCoreConnect Inc. | 15.12 Million USD | -247.261% |
| Augmedix, Inc. | 40.3 Million USD | -30.306% |
| BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 95.918% |
| CareCloud, Inc. | 93.35 Million USD | 43.743% |
| CareCloud, Inc. | 93.35 Million USD | 43.743% |
| HealthEquity, Inc. | 401.74 Million USD | 86.927% |
| Inovalon Holdings, Inc. | 427.99 Million USD | 87.729% |
| Nutex Health, Inc. | 66.54 Million USD | 21.079% |
| OneMedNet Corporation | 8.24 Million USD | -536.888% |
| Progyny, Inc. | 176.61 Million USD | 70.263% |
| Omnicell, Inc. | 534.79 Million USD | 90.179% |
| Renalytix Plc | 29.04 Million USD | -80.848% |
| Schrödinger, Inc. | 318.14 Million USD | 83.492% |
| Simulations Plus, Inc. | 37.02 Million USD | -41.869% |
| SOPHiA GENETICS SA | 117.73 Million USD | 55.393% |
| Streamline Health Solutions, Inc. | 31.19 Million USD | -68.387% |
| Minerva Surgical, Inc. | 58.14 Million USD | 9.668% |
| GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.043% |
| Sharecare, Inc. | 225.97 Million USD | 76.758% |
| Aclarion, Inc. | 4.87 Million USD | -977.188% |
| CareMax, Inc. | 670.05 Million USD | 92.162% |
| Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | -867.696% |
| Forian Inc. | 20.59 Million USD | -154.96% |
| Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -867.696% |
| HeartBeam, Inc. | 15.31 Million USD | -242.954% |
| GeneDx Holdings Corp. | 224.28 Million USD | 76.583% |
| SCWorx Corp. | 2.71 Million USD | -1831.067% |
| Definitive Healthcare Corp. | 546.47 Million USD | 90.389% |
| 10x Genomics, Inc. | 674.94 Million USD | 92.219% |
| Zhongchao Inc. | 13.92 Million USD | -277.232% |
| Accolade, Inc. | 306.51 Million USD | 82.865% |
| MSP Recovery, Inc. | 565.43 Million USD | 90.711% |
| R1 RCM Inc. | 336.6 Million USD | 84.397% |
| Spok Holdings, Inc. | 90.97 Million USD | 42.272% |
| Privia Health Group, Inc. | 134.31 Million USD | 60.899% |
| EUDA Health Holdings Limited | 4.8 Million USD | -993.454% |
| TruBridge, Inc. | 206.17 Million USD | 74.526% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 95.918% |
| Sharecare, Inc. | 225.97 Million USD | 76.758% |
| Health Catalyst, Inc. | 258.73 Million USD | 79.701% |
| GoodRx Holdings, Inc. | 710.34 Million USD | 92.606% |
| Premier, Inc. | 683.65 Million USD | 92.318% |
| HealthStream, Inc. | 168.02 Million USD | 68.742% |
| Certara, Inc. | 254.08 Million USD | 79.33% |
| GeneDx Holdings Corp. | 224.28 Million USD | 76.583% |
| Ontrak, Inc. | 29.47 Million USD | -78.185% |
| SHL Telemedicine Ltd. | 34.26 Million USD | -53.267% |
| CareCloud, Inc. | 93.35 Million USD | 43.743% |
| EUDA Health Holdings Limited | 4.8 Million USD | -993.454% |
| HeartBeam, Inc. | 15.31 Million USD | -242.954% |
| Mangoceuticals, Inc. | 9.65 Million USD | -444.227% |
| CareMax, Inc. | 670.05 Million USD | 92.162% |
| Healthcare Triangle, Inc. | 18.12 Million USD | -189.766% |
| Aclarion, Inc. | 4.87 Million USD | -977.188% |
| OptimizeRx Corporation | 69.3 Million USD | 24.215% |